REPL Earnings & Financial Statements
Replimune Group, Inc.
$13.10
-$0.10(-0.76%)
43
Overall
60
Value
60
Tech
10
Quality
Market Cap
$1.24B
Volume
744.83K
52W Range
$1.50 - $16.33
Target Price
$19.50
REPL earnings and financial statements: Replimune Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
REPL Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating income | -$319.92M | -$261.63M | -$234.77M | -$177.08M | -$118.31M |
| EBITDA | -$299.10M | -$232.29M | -$206.03M | -$173.07M | -$111.49M |
| Net income | -$313.94M | -$247.30M | -$215.79M | -$174.28M | -$118.04M |
| EPS (diluted) | $-3.38 | $-3.07 | $-3.24 | $-2.99 | $-2.26 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $332.39M | $551.33M | $487.72M | $646.55M | $461.24M |
| Total liabilities | $166.23M | $135.49M | $113.21M | $91.30M | $49.96M |
| Shareholders’ equity | $166.16M | $415.84M | $374.51M | $555.29M | $411.23M |
| Cash and equivalents | $209.02M | $111.12M | $74.46M | $146.59M | $105.95M |
| Long-term debt | $107.55M | $72.18M | $71.99M | $57.00M | $29.21M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$280.34M | -$192.25M | -$185.47M | -$128.05M | -$82.18M |
| Capital expenditure | -$4.22M | -$6.69M | -$5.66M | -$2.27M | -$2.34M |
| Free cash flow | -$284.57M | -$198.94M | -$191.13M | -$130.32M | -$84.52M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REPL | $13.10 | -0.8% | 744.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |